SEBI Reg. Investment Advisor

Download App

MoneyWorks4Me

Cadila Healthcare informs about press release

19 Feb 2016 Evaluate

Cadila Healthcare has informed about a press release dated February 19, 2016 titled ‘Zydus to commence supplies to the US market from its formulation manufacturing facility at SEZ’.

The above information is a part of company’s filings submitted to BSE.

Zydus Lifesciences Share Price

941.20 -1.35 (-0.14%)
20-Apr-2026 10:01 View Price Chart
Peers
Company Name CMP
Sun Pharma Inds. 1674.25
Dr. Reddys Lab 1235.85
Cipla 1236.25
Zydus Lifesciences 941.20
Lupin 2336.25
View more..

About MoneyWorks4Me

MoneyWorks4Me is a SEBI-registered Investment Adviser (IA) dedicated to helping investors build long-term wealth through transparent, research-driven, conflict-free guidance. Founded in 2008, we started our journey as a Research Analyst (RA), providing deep fundamental analysis, intrinsic value insights, and long-term investing frameworks for Indian equities. In 2017, we transitioned to a full-fledged SEBI-registered Investment Adviser, strengthening our commitment to acting as a fiduciary—always putting the investor’s interest first.

Our Vision

To become India’s most trusted, research-powered fiduciary advisory platform—where every investor, regardless of experience, can make calm, confident, and well-reasoned investment decisions.

What Makes MoneyWorks4Me Different

Our Approach: Ensuring compounding work its magic on client portfolio.

MoneyWorks4Me ensures this through:

×